BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10167177)

  • 1. A public health perspective on the control of predictive screening for breast cancer.
    Cunningham GC
    Health Matrix Clevel; 1997; 7(1):31-48. PubMed ID: 10167177
    [No Abstract]   [Full Text] [Related]  

  • 2. Panel softens cancer gene test warning.
    Wadman M
    Nature; 1996 Apr; 380(6575):573. PubMed ID: 8602252
    [No Abstract]   [Full Text] [Related]  

  • 3. US urged to monitor some genetic tests.
    Wadman M
    Nature; 1997 Feb; 385(6616):477. PubMed ID: 9020348
    [No Abstract]   [Full Text] [Related]  

  • 4. Breast cancer, the genetic "quick fix," and the Jewish community. Ethical, legal, and social challenges.
    Rothenberg KH
    Health Matrix Clevel; 1997; 7(1):97-124. PubMed ID: 10167180
    [No Abstract]   [Full Text] [Related]  

  • 5. FDA regulation of genetic testing: institutional reluctance and public guardianship.
    Huang A
    Food Drug Law J; 1998; 53(3):555-91. PubMed ID: 10346728
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical implications of BRCA1 genetic testing for Ashkenazi-Jewish women.
    Wiesner GL
    Health Matrix Clevel; 1997; 7(1):3-30. PubMed ID: 10167176
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictive genetic testing: from basic research to clinical practice.
    Holtzman NA; Murphy PD; Watson MS; Barr PA
    Science; 1997 Oct; 278(5338):602-5. PubMed ID: 9381169
    [No Abstract]   [Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA to regulate direct-to-consumer genetic tests.
    Brower V
    J Natl Cancer Inst; 2010 Nov; 102(21):1610-2, 1617. PubMed ID: 20966430
    [No Abstract]   [Full Text] [Related]  

  • 10. Commercialization of genetic testing services: the FDA, market forces, and biological tarot cards.
    Malinowski MJ; Blatt RJ
    Tulane Law Rev; 1997 Mar; 71(4):1211-312. PubMed ID: 15744901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jewish theological and moral reflections on genetic screening: the case of BRCA1.
    Dorff EN
    Health Matrix Clevel; 1997; 7(1):65-96. PubMed ID: 10167179
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA resists regulatory role in gene tests.
    Wadman M
    Nature; 1996 Nov; 384(6605):101. PubMed ID: 8906776
    [No Abstract]   [Full Text] [Related]  

  • 13. [Federal judge and government of the United States against gene patenting].
    Cassier M; Stoppa-Lyonnet D
    Med Sci (Paris); 2011; 27(6-7):662-6. PubMed ID: 21718652
    [No Abstract]   [Full Text] [Related]  

  • 14. Multigene classifiers, prognostic factors, and predictors of breast cancer clinical outcome.
    Ross JS
    Adv Anat Pathol; 2009 Jul; 16(4):204-15. PubMed ID: 19546609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How are Jewish women different from all other women? Anthropological perspectives on genetic susceptibility testing for breast cancer.
    Press N; Burke W; Durfy S
    Health Matrix Clevel; 1997; 7(1):135-62. PubMed ID: 10167172
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic testing for BRCA1 and BRCA2: recommendations of the Stanford Program in Genomics, Ethics, and Society. Breast Cancer Working Group.
    Koenig BA; Greely HT; McConnell LM; Silverberg HL; Raffin TA
    J Womens Health; 1998 Jun; 7(5):531-45. PubMed ID: 9650154
    [No Abstract]   [Full Text] [Related]  

  • 17. Advertising genetic testing for breast cancer.
    Weber LJ; Bissell MG
    Clin Leadersh Manag Rev; 2004; 18(1):50-1. PubMed ID: 14968755
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the search for large genomic rearrangements impact BRCAPRO carrier prediction?
    Capalbo C; Buffone A; Vestri A; Ricevuto E; Rinaldi C; Zani M; Ferraro S; Frati L; Screpanti I; Gulino A; Giannini G
    J Clin Oncol; 2007 Jun; 25(18):2632-4; author reply 2634-5. PubMed ID: 17577048
    [No Abstract]   [Full Text] [Related]  

  • 19. Myriad Genetics embroiled in breast-cancer data fight - again.
    Check Hayden E
    Nature; 2016 May; 533(7604):449. PubMed ID: 27225096
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnostics. Amid debate, gene-based cancer test approved.
    Couzin J
    Science; 2007 Feb; 315(5814):924. PubMed ID: 17303724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.